Tucusituzumab

Jump to: navigation, search
Tucusituzumab
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
TargetIL-2
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Tucusituzumab

Articles

Most recent articles on Tucusituzumab

Most cited articles on Tucusituzumab

Review articles on Tucusituzumab

Articles on Tucusituzumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tucusituzumab

Images of Tucusituzumab

Photos of Tucusituzumab

Podcasts & MP3s on Tucusituzumab

Videos on Tucusituzumab

Evidence Based Medicine

Cochrane Collaboration on Tucusituzumab

Bandolier on Tucusituzumab

TRIP on Tucusituzumab

Clinical Trials

Ongoing Trials on Tucusituzumab at Clinical Trials.gov

Trial results on Tucusituzumab

Clinical Trials on Tucusituzumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tucusituzumab

NICE Guidance on Tucusituzumab

NHS PRODIGY Guidance

FDA on Tucusituzumab

CDC on Tucusituzumab

Books

Books on Tucusituzumab

News

Tucusituzumab in the news

Be alerted to news on Tucusituzumab

News trends on Tucusituzumab

Commentary

Blogs on Tucusituzumab

Definitions

Definitions of Tucusituzumab

Patient Resources / Community

Patient resources on Tucusituzumab

Discussion groups on Tucusituzumab

Patient Handouts on Tucusituzumab

Directions to Hospitals Treating Tucusituzumab

Risk calculators and risk factors for Tucusituzumab

Healthcare Provider Resources

Symptoms of Tucusituzumab

Causes & Risk Factors for Tucusituzumab

Diagnostic studies for Tucusituzumab

Treatment of Tucusituzumab

Continuing Medical Education (CME)

CME Programs on Tucusituzumab

International

Tucusituzumab en Espanol

Tucusituzumab en Francais

Business

Tucusituzumab in the Marketplace

Patents on Tucusituzumab

Experimental / Informatics

List of terms related to Tucusituzumab


Overview

Tucusituzumab is a humanized monoclonal antibody used to treat cancers of the epithelial origin. It binds to interleukin-2.



Linked-in.jpg